Cubist Systematic Strategies, LLC Harpoon Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.78 - $5.02 $27,298 - $76,986	-15,336 Reduced 82.67%	3,214 $6,000
Q1 2022 May 16, 2022	BUY	$3.54 - $8.08 $62,831 - $143,411	17,749 Added 2215.86%	18,550 $92,000
Q4 2021 Feb 14, 2022	SELL	$5.69 - $7.83 $252,180 - $347,025	-44,320 Reduced 98.22%	801 $6,000
Q3 2021 Nov 15, 2021	BUY	$7.88 - $14.0 $277,738 - $493,444	35,246 Added 356.92%	45,121 $356,000
Q2 2021 Aug 16, 2021	SELL	$13.81 - $23.25 $4,723 - $7,951	-342 Reduced 3.35%	9,875 $137,000
Q1 2021 May 17, 2021	BUY	$17.65 - $24.16 $179,341 - $245,489	10,161 Added 18144.64%	10,217 $214,000
Q4 2020 Feb 16, 2021	SELL	$12.83 - $17.84 $25,813 - $35,894	-2,012 Reduced 97.29%	56 $1,000
Q3 2020 Nov 16, 2020	BUY	$11.01 - $18.52 $22,768 - $38,299	2,068 New	2,068 $35,000

353K

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.